Computational Analysis of Binding Interactions between the Ryanodine Receptor Type 2 and Calmodulin

D'Artagnan Greene1, Michael Barton1, Tyler Luchko1

  • 1Department of Physics, California State University, Northridge, California 91330, United States.

Insights

Mutations in cardiac ryanodine receptor type 2 (RyR2) cause arrhythmias. This study identifies key RyR2-calmodulin interactions, revealing how mutations can increase binding affinity to potentially treat cardiac conditions.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Biophysics

Background:

  • Mutations in cardiac ryanodine receptor type 2 (RyR2) are associated with cardiac arrhythmias like catecholaminergic polymorphic ventricular tachycardia (CPVT).
  • RyR2 function is modulated by calmodulin (CaM); disrupted RyR2-CaM interaction leads to abnormal calcium release and arrhythmias.
  • Enhancing RyR2-CaM binding affinity has shown potential in rescuing CPVT-related RyR2 channel function.

Purpose of the Study:

  • To elucidate the specific interactions governing calmodulin binding to RyR2.
  • To understand how mutations at the RyR2-CaM interface affect binding affinity.
  • To provide insights for potential therapeutic strategies targeting RyR2-CaM interactions.

Main Methods:

  • Computational analysis of RyR2-CaM binding interfaces.
  • Identification of key interaction domains and novel binding sites.
  • Comparative analysis of wild-type RyR2 and a V3599K mutant.

Main Results:

  • Key domains and several previously unidentified interactions critical for CaM binding to RyR2 were identified.
  • The study suggests that altering CaM's binding contacts in the central and N-terminal lobes can enhance RyR2-CaM binding affinity.
  • The V3599K mutation provides a model for understanding how affinity can be modulated.

Conclusions:

  • This research clarifies the molecular basis of RyR2-CaM interaction and the impact of mutations.
  • The findings offer a computational basis for designing drugs to modulate RyR2-CaM binding.
  • This work contributes to developing novel treatments for cardiac arrhythmias by targeting RyR2 function.

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.4K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
951
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.6K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.3K